In light of the research findings, charity Pancreatic Cancer UK today (Wednesday 26 May) launches its ‘Transform Lives: Prescribe’ campaign, urging the NHS to ensure everyone who could benefit from the tablets, known as Pancreatic Enzyme Replacement Therapy (PERT), are prescribed them at the point of diagnosis. Read more . . .
A University of Birmingham-led study has found almost half of people diagnosed within inoperable pancreatic cancer are not prescribed inexpensive yet essential tablets without which they cannot digest food – placing them at risk of starvation or being less able to tolerate treatment.